Medifast (NYSE: MED) has nearly $170 million in cash, no debt, insider buying and a bold strategic pivot through Trilivy. But shrinking revenues and GLP-1 competition still cast a long shadow. Here's the complete bull vs. bear case.

Read entire article

SiteOne Landscape Supply isn't flashy—but it may be one of the market's most overlooked industrial compounders. After a sharp correction, CEO Doug Black invested more than $816,000 of his own money while institutions continue to dominate the shareholder base. We examine the valuation, competitive moat, earnings, risks, and whether this roll-up story deserves another look.

Read entire article

Huntsman isn't simply a cyclical chemical company anymore. Between repeated insider buying, a transformational $12.5 billion merger with Olin, trading at just 0.64x book value and more than $400 million in projected synergies, investors may be looking at one of the market's more intriguing industrial turnaround opportunities.

Read entire article

PayPal has lost more than 85% of its value since 2021, yet it continues to grow revenue, generate billions in free cash flow, and aggressively repurchase shares. Has Wall Street become too pessimistic, or is PYPL a classic value trap? We examine the bull case, the risks, and what could reignite growth.

Read entire article

RH isn't just selling luxury furniture anymore—it's trying to redefine luxury living. With a major insider purchase, elevated short interest, ambitious global expansion, and Wall Street split on the outlook, RH may be one of today's most intriguing turnaround stories.

Read entire article

Autodesk isn't trying to beat AI—it may be one of the companies best positioned to integrate it. With executives buying shares, free cash flow soaring 58%, and a surprisingly attractive PEG ratio, ADSK deserves another look.

Read entire article

Krispy Kreme shares remain down more than 80% from their highs, but insiders—including former 3G Capital executive Bernardo Hees—are buying aggressively. With free cash flow finally turning positive and margins improving, the iconic doughnut maker may be entering a new chapter.

Read entire article

Globant (NYSE: GLOB) may be one of the most intriguing AI-related value plays on the market. Trading 87% below its peak, the company combines a growing AI-native services platform, accelerating cash flow, aggressive share buybacks, institutional ownership above 100% of float, and a historic first insider purchase from former Hong Kong Exchange CEO Alejandro Aguzin. Is Wall Street missing the story?

Read entire article

AECOM (NYSE: ACM) may be one of the most misunderstood infrastructure stocks in the market. With a record $26.2 billion backlog, insider buying from top executives, and a surprisingly cheap valuation, this engineering and consulting powerhouse could be quietly laying the foundation for substantial long-term upside.

Read entire article

Fortune Brands Innovations (FBIN) is under pressure from weak housing demand, shrinking profits, and leadership uncertainty. But while Wall Street hesitates, activist investor Ed Garden just made a massive $13.6 million insider purchase. Is this a value trap… or a smart-home turnaround hiding in plain sight?

Read entire article